followed patients with moderate-to-severe atopic dermatitis who switched from Dupixent (dupilumab) to Rinvoq (upadacitinib). It was found that those who continued with Rinvoq maintained high levels of skin and itch improvement. However, patients who switched from Dupixent to Rinvoq experienced additional improvements in their skin condition within just four weeks. Most patients who didn\u2019t respond well to Dupixent showed better results with Rinvoq, and the safety of Rinvoq over 40 weeks was consistent with previous studies, showing no new safety concerns.<\/span><\/p>\nAlways consult a healthcare provider to determine the most appropriate treatment option for your condition.\u00a0<\/span><\/p>\nRinvoq vs. Dupixent: Insurance coverage and cost comparison<\/span><\/h2>\nMost insurance plans typically cover Rinvoq and Dupixent. However, the extent of coverage can vary based on the specifics of your health plan. Medicare Part D coverage for these drugs may also differ and should be confirmed with your insurance provider. Rinvoq, being a newer treatment, may have lower coverage rates across different plans than Dupixent.<\/span><\/p>\nThe average retail cost of Rinvoq and Dupixent without insurance can vary widely, but with discounts or assistance programs, the price may be reduced. A one-month supply of Rinvoq without insurance may cost around $8,000, while a one-month supply of Dupixent without insurance is around $5,000. Using a <\/span> discount card<\/span> may help offset the out-of-pocket costs of these medications.\u00a0<\/span><\/p>\n\n\n\n\nCompare coverage & cost of Rinvoq vs. Dupixent<\/span><\/h3>\n<\/th>\n<\/tr>\n<\/thead>\n\n\n| Typically covered by insurance?<\/b><\/td>\n | Yes<\/span><\/td>\n | Yes<\/span><\/td>\n<\/tr>\n\n| Typically covered by Medicare Part D?<\/b><\/td>\n | Yes<\/span><\/td>\n | Yes<\/span><\/td>\n<\/tr>\n\n| Quantity<\/b><\/td>\n | 30, 15 mg tablets<\/span><\/td>\n | 2, 2 ml of 300 mg\/2 ml pens<\/span><\/td>\n<\/tr>\n\n| Average retail price<\/b><\/td>\n | $8,291<\/span><\/td>\n | $5,139<\/span><\/td>\n<\/tr>\n\n| cost<\/b><\/td>\n | $5,900<\/span><\/td>\n | $3,603<\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n \u00a0<\/p>\n Dupixent vs. Rinvoq side effects<\/span><\/h2>\nDupixent and Rinvoq carry a risk of various side effects. The types of side effects and their severity can depend on the medication and dosage.\u00a0<\/span><\/p>\nThe most common side effects of Rinvoq include upper respiratory infections, such as the common cold, nausea, acne, headache, cough, fatigue, weight gain, muscle pain, and fever. On the other hand, the most common side effects of Dupixent include injection site reactions, which can cause redness, swelling, itching, and joint pain. Dupixent can also cause eye problems, such as inflammation, redness, itching, and dryness in the eyes.\u00a0<\/span><\/p>\n <\/b>Dupixent face rash and redness: Causes and treatment<\/b><\/p>\n Both medications have been linked to an increased risk of <\/span>herpes simplex<\/span> virus reactivation, which includes cold sores and herpes keratitis, particularly in individuals who carry the virus. Both medications can also lead to serious, although less frequent, side effects. For example, Rinvoq may increase the risk of serious infections, while Dupixent has been linked to severe allergic reactions.<\/span><\/p>\n | | | | | |
![](\"https:\/\/www.singlecare.com\/blog\/wp-content\/themes\/singlecare\/images\/union.svg\")
<\/span>